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Abstract
OBJECTIVE: To observe the clinical efficacy of
bloodletting therapy and acupuncture at Jiaji
points for treating upper back myofascial pain syn-
drome (MPS), and compare this with lidocaine
block therapy.
METHODS: A total of 66 upper back MPS patients
were randomly assigned to either the treatment
group or the control group in a 1∶1 ratio. The treat-
ment group (n = 33) were treated with bloodletting
therapy at local myofascial trigger points and acu-
puncture at Jiaji (EX-B 2) points; one treatment
course consisted of five, single 20-min-treatments
with a 2-day break between each treatment. The
control group (n = 33) were treated with a lidocaine
block at trigger points; one treatment course con-
sisted of five sessions of lidocaine block therapy
with a 2-day break between each session. The sim-
plified McGill Scale (SF-MPQ) and tenderness
threshold determination were used to assess pain
before and after a course of treatment.
RESULTS: After the third and fifth treatment, the
SF-MPQ values were significantly decreased (P <
0.01) and the tenderness thresholds were signifi-
cantly increased (P < 0.01) in both groups com-
pared with before treatment. There were no signifi-
cant differences in pain assessments between the
two groups after three and five treatments (P >
0.05). There were five cases with minor adverse re-
actions reported in the control patients, while no
adverse reactions were reported in the treatment
group.
CONCLUSION: Bloodletting therapy at local myo-
fascial trigger points and acupuncture at Jiaji
points was effective in treating upper back MPS.
Clinically, bloodletting and acupuncture therapy
had the same efficacy as the lidocaine block thera-
py, with fewer adverse reactions.
© 2016 JTCM.
Key words: Myofascial pain syndromes; Acupunc-
ture; Bloodletting; Treatment outcome; Random-
ized controlled trial
INTRODUCTION
Myofascial pain syndrome (MPS) is originally generat-
ed within connective tissue such as muscles, tendons
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and fascia. MPS is a common cause of neck pain, lum-
bar pain and pain around the major joints.1 Myofascial
trigger points (MTrPs) are a major clinical feature of
MPS.
The most common treatment for MPS in Western
Medicine is local block therapy, usually lidocaine.2
Muscle stretch therapy3,4 dry needle therapy5 and oral
non-steroidal anti-inflammatory drugs6 are also com-
monly used. However, there are limitations of these
treatments, such as adverse reactions to anesthetic and
oral medications, and intense pain associated with dry
needle therapy and muscle stretch therapy.6-8
The analgesic effect of acupuncture is recognized
worldwide. Local acupuncture is mainly used in the
treatment of MPS; this relieves pain by damaging the
trigger points and improving local circulation. Howev-
er, there is a lack of specific treatment programs target-
ing repeated pain caused by spinal segmental sensitiza-
tion and central sensitization. Because Jiaji (EX-B 2)
has special anatomic and physiologica functions, it was
used in treating many diseases, especially in acupunc-
ture analgesia.9-17 The skin over the trigger points
(TrPs) is pricked to release blood, and acupuncture is
performed at the Jiaji (EX-B 2) points where the TrPs
are located.
The purpose of this study was to evaluate the clinical
efficacy of bloodletting and Jiaji (EX-B 2) acupuncture
treatment for upper back MPS, and compare this with
the efficacy of lidocaine block therapy.
MATERIALS ANDMETHODS
This study was approved by the Ethics Committee of
Guangdong Provincial Traditional Chinese Medicine
Hospital. All participants provided written informed
consent.
A total of 66 participants were randomly divided into
two groups at a 1∶1 ratio of treatment group (n = 33)
to control group (n = 33). All participants were outpa-
tients of the Physiotherapy Department of Guangdong
Provincial Hospital of TCM from October 2011 to
June 2013.
The random digits were generated by SPSS 11.0 soft-
ware (SPSS Inc., Chicago, IL, USA) and were loaded
in the envelopes. The corresponding envelopes were se-
lected according to the sequence of the participants,
and the method in it was used in the research.
Because the treatment method is different, so the blind
method can't be used. Only in the data collation and
statistical analysis phase, there was a assign specific per-
son to manage the data.
Diagnostic criteria of myofascial pain syndrome3,4
(a) Medical history of pain associated with some degree
of mechanical abuse of the muscle in the form of mus-
cle overload, which may have been acute, sustained
and/or repetitive. (b) Palpation along the taut muscle
band reveals a nodule exhibiting a highly localized, ex-
tremely tender spot known as a TrP. (c) In addition to
referring pain to the reference zone, TrPs may cause
other sensory changes such as tenderness and dysesthe-
sia. (e) Muscles with active MTrPs have a restricted pas-
sive (stretch) range of motion because of pain. (f ) The
taut muscle band fibers respond consistently with a
twitch response when the TrP is penetrated by a nee-
dle. (g) The patient feels pain when the muscle is
strongly contracted against fixed resistance. (h)Sleep
disturbance can increase pain sensitivity.
Traditional Chinese Medicine (TCM) syndrome
differentiation
According to the Criteria of diagnosis and therapeutic
effect of diseases and syndromes in TCM assigned by
the State Administration of TCM,18 back myofasciitis
can be summarized into three syndromes: internal
pathogen with wind, cold and dampness; stagnation of
Qi and blood; and deficiency of Qi and blood.
Inclusion criteria
(a) Diagnosed with MPS according to the above men-
tioned diagnostic criteria. (b) Aged 20-60 years. (c)
Provided written informed consent.
Exclusion criteria
(a) Comorbid diseases including cervical spondylosis,
cervical and spinal tuberculosis, ankylosing spondylitis,
cervical tumor, severe pain caused by psychological fac-
tors and other organic pathologic changes. (b) Hyper-
sensitivity to drugs, injections, and/or acupuncture. (c)
Severe cardiovascular and respiratory disease. (d) Tak-
ing conflicting or related medicine during the study.
(e) Mental or psychiatric disease. (f ) Pregnant women.
(g) Patients intolerant of or uncooperative with the
study.
Treatment
Treatment group: to locate the MTrPs, each patient
pointed out their painful area, which the doctor then
pressed with their thumbs to confirm the presence of a
tense muscle band. The doctor pressed the TrP to bring
out the circumscribed pain and spasm, and then en-
hanced the stimulus to induce referred pain. When the
pain was induced, patients were asked whether it felt
similar to the pain that usually occurs. To quantitative-
ly evaluate the MTrPs, a tenderness meter with a 1 cm2
spring end was placed on the major MTrPs. Pressure
was applied, and the threshold of tenderness was mea-
sured. A threshold of tenderness of 2 kg/cm2 or below
was regarded as abnormal. When the MTrPs were locat-
ed, an X was drawn on it with inerasable ink. Each
MTrP was held steady with the doctor's non-dominant
hand, and then the dominant hand was used to stab
the triangle-edged needle (Hanyi triangle-edged nee-
dle, 6.5 cm length, 0.5 mm tip length and 1.6 mm di-
ameter. Manufactured by Changchun AIK Medical De-
vices Co., Ltd. Address: No. 25 karan Industrial park,
jiutai Econimic Development Zone, Changchun.
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130507, China) into the MTrP about 0.2 mm deep,
and then quickly remove the needle. This was repeated
three times to bleed the MTrP.
After bloodletting, the glass cups were cupped on the
bleeding area for 10 min. The left hand held the hemo-
static clamping 95% alcohol cotton, right hand held
glass cup. After the fire lighted alcohol cot, quickly ro-
tated lighting cotton 1-3 turning in the cup, exited
quickly, immediately covered the cup on the bleeding
sites. Ten minutes later, the cups were withdrew and
gore was abrased by disinfected cotton swab.
After cupping, acupuncture needles were inserted into
the MTrPs. When the patient felt radiating pain or oth-
er unusual feelings on the acupoints, the needle was
lifted to the subcutaneous level and aimed toward the
tense muscle band or the string-like structure in the
muscle. To apply acupuncture to the Jiaji (EX-B 2) on
the related spinal segment, the needle (Hanyi dispos-
able Acupuncture needle, 25 mm tip length and
0.25 mm diameter. Manufacturer and the place of
manufacture is the same with above) insertion depth
was about 0.5 cun (25 mm equals to 1 cun) and the ma-
nipulation was neutral. The patients had a sense of radi-
ating pain to other area, or acid or expansion at the
part of the needle. A treatment course consisted of
five, single 20-min-treatments with a 2-day break be-
tween each treatment. The MTrPs were relocated be-
fore each treatment.
Control group: the MTrPs were located and marked
with an X as described above; no more than three dif-
ferent points were chosen each time for lidocaine block
therapy. The solution consisted of 2 mL of 2% lido-
caine mixed with 6 mL of 0.9% saline, of which 2 mL
was injected at each TrP. Lidocaine was purchased from
Shanxi Jinxin Shuanghe Pharmaceutical Co., Ltd. (Yun
Cheng City, Shanxi, China).
A treatment course consisted of five sessions of lido-
caine block therapy with a 2-day break between each
session. The MTrPs were relocated before each treat-
ment. Attention was paid to the angle and depth of
needle insertion to prevent pneumothorax.
Outcome measurements
The simplified McGill scale (SF-MPQ)19 consisting of
the pain rating index (PRI), visual analog pain scale
(VAS), and present pain intensity (PPI).
Evaluation of the tendernessthreshold20 was performed
using a push-pull force gauge (Fabrication Enterprises,
Inc., New York city, USA) to measure the pressure pain
threshold (PPT) and the pain tolerance threshold
(PTT). The PPT is the force value at which the patient
feels the pressure turn into pain. The PTT is the maxi-
mum force value that the patient can tolerate. Because
too much pressure also cause a noxious stimulation to
the patients, so we also set a value. When the patient's
PTT was higher than 10 kg/cm2, the measurement was
halted and this set value was recorded as the patient's
PTT. In each case the threshold of pain was measured
five times, with a 10-15 s break between each measure-
ment; themean valuewas recorded as the PPT andPTT.
Adverse reactions we related to the therapy were record-
ed, including subcutaneous hemorrhage and hemato-
ma, hypersensitivity, palpitations and dizziness.
Data management and statistical analysis
All clinical data were recorded on a specific clinical re-
search form and managed by a specific person excluded
from the researchers and therapists. Statistical analysis
was done using SPSS11.0 software (SPSS Inc., Chica-
go, IL, USA). Quantitative data were recorded as mean
± standard deviation and tested for normality. If the da-
ta were normally distributed, the independent t-testwas
used; the paired t-test was used for comparing data be-
tween different treatment stages. Ranked data was test-
ed with the two sample Wilcoxon rank sum test. Val-
ues of α > 0.05 (two sides) and P < 0.05 were consid-
ered statistically significant.
RESULTS
The study was a randomized controlled trial. The re-
search process is shown in Figure 1. In the treatment
group, nine patients were male and 24 were female,
with an average age of (35 ± 7) years and an average du-
ration of illness of (2.9 ± 4.2) months. The TCM syn-
drome differentiations included internal pathogen with
wind, cold and dampness (10 cases), stagnation of Qi
and blood (20 cases), and deficiency of Qi and blood
(2 cases). In the control group, 15 patients were male
and 18 were female, with an average age of (37 ± 9)
years and an average duration of illness of (5 ± 6)
months. The TCM syndrome differentiation included
internal pathogen with wind, cold and dampness (7
cases), stagnation of Qi and blood (24 cases), and defi-
ciency of Qi and blood (3 cases). There were no signifi-
cant differences between the two groups in age, sex, du-
ration of illness and prevalence of TCM syndrome dif-
ferentiation (P > 0.05 for all parameters).
Data analysis
statistical data (n = 66)
Eligible subjects
Inform and sign on the
informed consent (n = 66)
Random
Teatment group (n = 33) Control group (n = 33)
Assessment before,
after 3rd and 5th
TreatmentSF-MPQevaluation of the tender-
ness threshold (n = 66)
Establish database (n = 66)
Figure1 Flow diagram of the study process
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Curative effect according to the simplified McGill
scale
There were no significant differences between the two
groups before treatment regarding PRI, VAS and PPI
(P > 0.05). Acupuncture and bloodletting at the Jiaji
(EX-B2) and lidocaine block therapy both had a signifi-
cant effect on the SF-MPQ. The PRI, VAS and PPI af-
ter the third and the fifth treatments were significantly
decreased compared with before treatment in both
groups (P < 0.01).The PRI, VAS and PPI after the
fifth treatment were significantly lower than after the
third therapy in both groups (P < 0.01). There were
no significant differences in PRI, VAS, and PPI be-
tween the two groups after the third and fifth treat-
ments (P > 0.05) (Table 1).
Curative effect according to the tenderness thresholds
There were no significant differences between the two
groups in PPT and PTT before treatment (P > 0.05).
Acupuncture and bloodletting at the Jiaji (EX-B 2)
points and lidocaine block therapy both had a signifi-
cant effect on the tenderness thresholds. The PPT and
PTT after the third and fifth treatment were signifi-
cantly increased in both groups compared with before
treatment (P < 0.01). The PPT and PTT after the fifth
treatment were significantly higher than after the third
treatment in both groups (P < 0.01). There were no
significant differences between the PPT and PTT of
the two groups after the third and fifth treatment (P >
0.05) (Table 2).
Adverse reactions
No adverse reactions were observed in the treatment
group during the study. In the control group, transient
hypertension that was relieved after a brief rest was re-
ported in two cases, and insomnia after treatment was
reported in three cases. All cases finished the entire
study and no further adverse reactions were reported
during the study.
DISCUSSION
An MTrP is a region on the affected muscle that causes
pain; in most cases a taut band (string-like tubercle) is
palpable on this region. Touching or pressing this re-
gion can lead to local pain; and inferred pain or tender-
ness in a remote area and sympathetic phenomenon
can also be induced. Stimulation of MTrPs can make
the muscle feel soft and 'doughy', cause distraction of
skeletal muscle, and decrease range of motion.2,3
The exact physiological mechanism of MTrPs has not
yet been completely clarified. One theory is the energy
crisis hypothesis.21 Dysfunction of the motor endplate
occurs in the affected skeletal muscle, which leads to ex-
cessive release of acetylcholine in the nerve terminal of
the motor endplate, and continuous depolarization of
cell membranes. More calcium is then released by the
sarcoplasmic reticulum, resulting in continuous sarco-
mere contraction and the formation of a tense muscle
band and tubercle.21 The continuous sarcomere con-
traction increases the local energy consumption and de-
creases the blood perfusion of the muscle. Hypoxia and
ischemia of the muscle provokes the release of neural
vascular reaction substances, which are inflammatory
mediators including bradykinin, substance P, calcitonin
gene related to peptide, tumor necrosis factor alpha, in-
terleukin(IL)-1β, IL-6, IL-8, and serotonin. These sub-
stances sensitize the afferent nerve, resulting in painful
TrPs. This process can also be defined as peripheral sen-
sitization.21 The neural vascular reaction substances
cause the release of additional acetylcholine, and the
Group
Treatment
Control
PRI
Before
19.7±5.5
20.9±6.4
After 3rd
therapy
9.4±4.3a
9.6±5.3a
After 5th
therapy
2.7±2.5ab
3.4±4.3ab
VAS
7.7±0.9
7.6±1.1
Before After 3rdtherapy
3.4±1.3a
3.6±1.4a
After 5th
therapy
1.0±1.5ab
0.8±1.0ab
PPI
Before
3.6±0.7
3.7±0.7
After 3rd
therapy
1.6±0.8a
1.7±0.9a
After 5th
therapy
0.5±0.8ab
0.4±0.6ab
Notes: treatment group: treated with bloodletting therapy at local myofascial trigger points and acupuncture at Jiaji (EX-B 2) points; con-
trol group: treated with lidocaine block at trigger points. PRI: pain rating index; VAS: visual analog pain scale; PPI: present pain intensity.
aP < 0.01, comparing values before and after treatment; bP < 0.01, comparing values after the third and fifth treatment. There were no sig-
nificant differences between the two groups (P > 0.05).
Table 1 Therapeutic effect according to the simplified McGill scale in the treatment and control groups (scores, xˉ ± s)
Group
Treatment
Control
PPT
Before
1.4±0.5
1.4±0.6
After 3rd therapy
3.0±0.6a
3.1±0.7a
After 5th therapy
4.6±0.8ab
4.5±0.8ab
PTT
Before
1.9±0.7
1.9±0.8
After 3rd therapy
3.7±0.7a
3.8±0.8a
After 5th therapy
5.4±0.9ab
5.3±0.9ab
Notes: treatment group: treated with bloodletting therapy at local myofascial trigger points and acupuncture at Jiaji (EX-B 2) points; con-
trol group: treated with lidocaine block at trigger points. PPT: pressure pain threshold; PTT: pain tolerance threshold. aP < 0.01, compar-
ing values before and after treatment; bP < 0.01, comparing values after the third and fifth treatment. There were no significant differences
between the two groups (P > 0.05).
Table 2 Therapeutic effect on the tenderness threshold in the treatment and control groups (kg/cm2, xˉ ± s)
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process forms a positive feedback loop.21 At the same
time, the concentration of noradrenaline rises and the
pH decreases.21
This peripheral sensitization can result in central ner-
vous system sensitization by provoking the sustained
discharge of nociceptors exiting the spinal dorsal horn
through the C-fibers and A-delta fibers; through this
process, transformation in function and structure
evolves, causing spinal segmental sensitization.22 The
clinical expression of spinal segmental sensitization in-
cludes hyperalgesia, pain at mild touch, referred pain,
and dysfunction of motor and autonomic nerve func-
tion.22 Sustained central nervous system sensitization
caused by pain enhances the excitation of neurons and
enlarges the receptor pool of neurons, thus inducing in-
tractable referred pain.23
Relieving MTrPs is the main method for treating
MPS. Reversing spinal segmental sensitization and cen-
tral nervous system sensitization are significant parts of
treatment. Injecting lidocaine into TrPs is universally
accepted as an effective method for treating MPS; how-
ever, injecting local anesthetics intramuscularly may
lead to myotoxicity.7,8 TrPs can also be treated by
bloodletting at MTrPs (also known as "Ahshi points"
in TCM theory). In the current study, bloodletting
therapy had an instant analgesic effect. According to
TCM theory, pain is due to the meridian blocked, in
which bloodletting dredges the affected meridian and
promotes the movement of Qi and blood; when the
meridian is dredged, pain is relieved. When local tissue
is damaged by noxious stimulation, it releases several
pain-producing substances, including K + , H + , S-HT,
and bradykinin. The pain-producing substances affect
free nerve endings and induce pain impulses.24 To
block the pain-inducing process, bloodletting therapy
expels the blood with a high concentration of pain-pro-
ducing substance, and draws fresh blood from a re-
mote area, thus lowering the concentration of pain-pro-
ducing substances, improving the local circulation, and
helping to repair damaged tissue.24 The treatment re-
duces neural vascular substances in the positive feed-
back loop of the energy crisis hypothesis, thus prevent-
ing MTrPs from developing.24
Jiaji (EX-B 2) points were chosen as acupoints in the
current study. Many studies have used Jiaji (EX-B 2)
points owing to their special anatomic and physiologi-
cal function, especially regarding pain treatment.9,10 Jia-
ji (EX-B 2) points are located between the Bladder Me-
ridian of Foot-Taiyang and the Du Meridian, and con-
nect the two meridians by a branch of the Du Meridi-
an. The Du Meridian gathers all the Yang Meridians,
and the Bladder Meridian of Foot-Taiyang is primary
to the Yang Meridians. Because Jiaji (EX-B 2) points
are located on two meridians, acupuncture at Jiaji
(EX-B 2) points can modify the function of both me-
ridians and inspire Yang Qi in the body. In terms of
their anatomical locations, Jiaji (EX-B 2) points and
their surrounding area travel around the dorsal rami of
the spinal nerves; 54.4% of the dorsal rami of spinal
nerves have a parallel location with the Jiaji (EX-B 2)
points in a horizontal direction. Some dorsal rami of
spinal nerves travel above or below the horizontal level
of Jiaji (EX-B 2) points, but the main area innervated
by the spinal nerve covers the Jiaji (EX-B 2) points.9
The widely distributed nerve endings in the acupoint
area, dorsal rami of spinal nerves, and the sympathetic
nerve stem spreading from the centrum form the physi-
ological basis of the therapeutic effects of acupuncture
at Jiaji (EX-B 2) points.10 Our previous study con-
firmed the effectiveness and stability of acupuncture at
Jiaji (EX-B 2) points for MPS.25
Based on the clinic and experimental research, we
think that acupuncture can relieve pain at three levels
in the route of pain transmission: the local periphery,
the spinal segment, and the central nervous system.
The TrPs are damaged by bloodletting, which reduces
the release of inflammatory mediators, and reverses the
sensitization of afferent nerves (peripheral sensitiza-
tion) to relieve myofascial pain. Afferent nerves protect
the spinal cord center from noxious stimulation. Acu-
puncture at Jiaji (EX-B 2) points sends a signal
through the spinal nerves to the related spinal segment.
When the noxious stimulation and the acupuncture
signalare sent to the same or nearby spinal segments,
acupuncture significantly reduces pain, thus reversing
spinal segmental sensitization. The acupuncture signal
can be sent into the cerebrum through the ventrolater-
al funiculus. In the frontal abdominal side of the me-
dulla oblongata, gray matter around the aqueduct of
the midbrain and the thalamus, noxious stimulation
and acupuncture signal gathers in the same cells and
nuclear groups. When they take effect at the same
time, noxious stimulation will be depressed by the acu-
puncture signal, thus reversing central nervous system
sensitization.
To evaluate the therapeutic effect of bloodletting and
acupuncture, we adopted the universally accepted
SF-MPQ and the threshold of tenderness. The
SF-MPQ is one of the most widely accepted scales
used for assessing all types of pain. The threshold of
tenderness includes the sensory and tolerance thresh-
olds of tenderness, which allows objective assessment
of the severity of pain and improvement after therapy.
In conclusion, bloodletting at TrPs and acupuncture at
Jiaji (EX-B 2) points lowered the SF-MPQ, and elevat-
ed the patients' sensory and tolerance tenderness
thresholds. Moreover, no adverse reactions were report-
ed in the treatment group. Acupuncture had a similar
therapeutic effect to lidocaine block, with fewer ad-
verse reactions. Acupuncture is an effective and practi-
cal method for MPS treatment.
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